GUJARAT THEMIS BIOSYN
Back to Cashflow Statement
|
GUJARAT THEMIS BIOSYN Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹91 Cr | ₹64 Cr | ₹39 Cr | ₹40 Cr | ₹11 Cr |
What is the latest Cash Flow from Operating Activities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹91 Cr |
| Mar2024 | ₹64 Cr |
| Mar2023 | ₹39 Cr |
| Mar2022 | ₹40 Cr |
| Mar2021 | ₹11 Cr |
How is Cash Flow from Operating Activities of GUJARAT THEMIS BIOSYN Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹91 Cr | 41.76 | |
| Mar2024 | ₹64 Cr | 62.66 | |
| Mar2023 | ₹39 Cr | -2.08 | |
| Mar2022 | ₹40 Cr | 282.80 | |
| Mar2021 | ₹11 Cr | - | |
Compare Cash Flow from Operating Activities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹3,926.7 Cr | 7.8% | 31% | 2.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | -2.9% | -8.9% | -3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,817.0 Cr | 1.2% | 4.2% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,297.0 Cr | -1.7% | -3.6% | 27.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,828.0 Cr | 6.8% | 1.3% | 13.2% | Stock Analytics | |
| CIPLA | ₹104,588.0 Cr | 5.4% | 3.1% | -13.6% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | 7.8% |
31% |
2.4% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses